SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001213900-18-003107
Filing Date
2018-03-16
Accepted
2018-03-16 17:28:26
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 11781
2 OFFERING CIRCULAR f1a2018a1_emeraldhealth.htm PART II AND III 876606
3 CONSENT OF DELOITTE & TOUCHE LLP f1a2018a1ex11-1_emerald.htm EX1A-11 CONSENT 1545
4 GRAPHIC image_001.jpg GRAPHIC 24042
5 GRAPHIC image_008.jpg GRAPHIC 37789
6 GRAPHIC image_009.jpg GRAPHIC 19290
7 GRAPHIC image_010.jpg GRAPHIC 24152
8 GRAPHIC image_006.jpg GRAPHIC 51351
  Complete submission text file 0001213900-18-003107.txt   1107424
Mailing Address 5820 NANCY RIDGE DRIVE ATTENTION: DR. JILL BROADFOOT SAN DIEGO CA 92121
Business Address 5820 NANCY RIDGE DRIVE ATTENTION: DR. JILL BROADFOOT SAN DIEGO CA 92121 858-361-4499
Emerald Health Pharmaceuticals Inc. (Filer) CIK: 0001700800 (see all company filings)

IRS No.: 820669961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-10810 | Film No.: 18696766
SIC: 2834 Pharmaceutical Preparations